Related Experiment Video

Updated: Jun 27, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Id-1: regulator of EGFR and VEGF and potential target for colorectal cancer therapy

Ibrahim Meteoglu1, Nezih Meydan, Muhan Erkus

  • 1Adnan Menderes University, Medical Faculty, Department of Pathology, 09100-Aydin/Turkey. imete69@hotmail.com

Journal of Experimental & Clinical Cancer Research : CR
|November 19, 2008
PubMed
Abstract

Insights

In colorectal carcinoma, Id-1, EGFR, and VEGF are linked to tumor progression. Id-1 expression correlates with EGFR and VEGF, suggesting they are potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • The helix-loop-helix transcription factor Id-1 influences tumor development and progression.
  • Id-1 is known to interact with epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF).

Purpose of the Study:

  • To investigate the relationship between Id-1, EGFR, and VEGF in colorectal carcinoma.
  • To determine if Id-1 expression correlates with tumor grade and stage.

Main Methods:

  • Immunohistochemical staining was performed on 46 colorectal carcinoma tissue specimens for Id-1, EGFR, and VEGF.
  • The correlation between staining intensity and tumor grade, stage, and markers was analyzed.

Main Results:

  • High positive staining for Id-1 (93.5%), EGFR (89%), and VEGF (91%) was observed in tumor cells.
  • Significant correlations were found between tumor grade and stage with Id-1, EGFR, and VEGF staining.
  • Id-1 expression was significantly associated with EGFR and VEGF expression.

Conclusions:

  • Id-1, EGFR, and VEGF are involved in the development and progression of colorectal cancer.
  • Id-1 is associated with the regulation of EGFR and VEGF in colorectal carcinoma.
  • Id-1, in addition to EGFR and VEGF, represents a potential therapeutic target for colorectal cancer treatment.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...